[1]CurrentPatentAssignee:AMGENINC-WO2014/210042,2014,A2Locationinpatent:Paragraph00273-00278
[1]CurrentPatentAssignee:AMGENINC-WO2014/210042,2014,A2Locationinpatent:Paragraph00279-00284
[1]CurrentPatentAssignee:AMGENINC-WO2014/210042,2014,A2
[1]CurrentPatentAssignee:AMGENINC-WO2014/210042,2014,A2
[1]CurrentPatentAssignee:AMGENINC-WO2014/210042,2014,A2
Title: Paul E. Hughes, et al. AMG 337, a novel, potent and selective MET kinase inhibitor, has robust growth inhibitory activity in MET-dependent cancer models. Cancer Res October 1, 2014 74; 728
Title: Cecchi F, et al. Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012 Jun;16(6):553-572.